Press release
OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande
ALBUQUERQUE, N.M. – OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River.The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program).
The P2 Program was created in 1992 to protect Albuquerque’s water treatment plant and the Rio Grande River from harmful waste runoff. The program recognizes businesses for reducing or eliminating the creation of pollutants at their source through equipment and process modifications, reformulation or redesign of products, substitution of raw materials, and improvements in housekeeping, maintenance, training or inventory control that results in reduced waste generation.
In OsoBio’s case, the company implemented changes to its raw materials processes, which reduced wastewater by 25 percent. The company also installed a state-of-the-art treatment system that improved the quality of water discharged from its facilities.
“OsoBio prides itself on being a conscientious corporate citizen in Albuquerque, which includes respecting the sensitive environment we share with our neighbors and doing our part to protect it from further degradation,” said Dr. Stuart Rose, president and CEO. “It is gratifying to know that by reducing OsoBio’s environmental footprint, we are making a positive contribution to our community.”
OsoBio is a contract manufacturing organization focusing on biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products that require complex handling, including highly potent compounds.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects. To learn more about our company and the value we offer clients, visit http://www.OsoBio.com
Sinclair & Co.
Karen Stinneford
619 Oberlin Road
Raleigh, NC 27605
919-833-9102
kstinneford@sinclair-co.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande here
News-ID: 174651 • Views: …
More Releases from Oso BioPharmaceuticals Manufacturing, LLC
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBi …
ALBUQUERQUE, N.M. – A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual.
Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by Jeanne Moldenhauer and being published in September by the Parenteral Drug Association.
Van Antwerpen’s key observation is that aseptic drug manufacturers should closely observe the environmental monitoring trends of their…
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of …
ALBUQUERQUE, N.M. – Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA).
Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being a featured speaker at events, she received the PDA’s Distinguished Author Award for her book, Understanding the United States Pharmacopeia and the National…
More Releases for OsoBio
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBi …
ALBUQUERQUE, N.M. – A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual.
Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by Jeanne Moldenhauer and being published in September by the Parenteral Drug Association.
Van Antwerpen’s key observation is that aseptic drug manufacturers should closely observe the environmental monitoring trends of their…
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of …
ALBUQUERQUE, N.M. – Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA).
Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being a featured speaker at events, she received the PDA’s Distinguished Author Award for her book, Understanding the United States Pharmacopeia and the National…
